$995 Million is the total value of Pale Fire Capital SE's 74 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 580.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STNG | Buy | SCORPIO TANKERS INC | $42,208,837 | +21.5% | 779,912 | +6.0% | 4.24% | +68.0% |
BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $6,071,800 | – | 70,000 | +100.0% | 0.61% | – |
DAR | Buy | DARLING INGREDIENTS INC | $4,630,140 | +81.5% | 88,700 | +121.8% | 0.46% | +151.4% |
TRIP | Buy | TRIPADVISOR INC | $2,647,179 | +435.1% | 159,661 | +432.2% | 0.27% | +638.9% |
VIRT | New | VIRTU FINL INCcl a | $1,721,284 | – | 99,669 | +100.0% | 0.17% | – |
CUZ | New | COUSINS PPTYS INC | $1,557,429 | – | 76,457 | +100.0% | 0.16% | – |
DHC | Buy | DIVERSIFIED HEALTHCARE TR | $681,151 | +111.4% | 351,109 | +145.2% | 0.07% | +195.7% |
NOMD | New | NOMAD FOODS LTD | $376,908 | – | 24,764 | +100.0% | 0.04% | – |
FLWS | New | 1 800 FLOWERS COM INCcl a | $351,855 | – | 50,265 | +100.0% | 0.04% | – |
RPHM | New | RENEO PHARMACEUTICALS INC | $113,090 | – | 14,851 | +100.0% | 0.01% | – |
IGMS | New | IGM BIOSCIENCES INC | $105,218 | – | 12,601 | +100.0% | 0.01% | – |
CELC | New | CELCUITY INC | $95,138 | – | 10,409 | +100.0% | 0.01% | – |
KNTE | Buy | KINNATE BIOPHARMA INC | $98,244 | +36.9% | 70,174 | +196.3% | 0.01% | +100.0% |
PRLD | New | PRELUDE THERAPEUTICS INC | $95,113 | – | 30,781 | +100.0% | 0.01% | – |
CMRX | New | CHIMERIX INC | $94,920 | – | 98,896 | +100.0% | 0.01% | – |
ALDX | New | ALDEYRA THERAPEUTICS INC | $98,196 | – | 14,700 | +100.0% | 0.01% | – |
EWTX | New | EDGEWISE THERAPEUTICS INC | $89,646 | – | 15,645 | +100.0% | 0.01% | – |
LIFE | New | ATYR PHARMA INC | $88,254 | – | 55,857 | +100.0% | 0.01% | – |
ACRS | New | ACLARIS THERAPEUTICS INC | $89,050 | – | 13,000 | +100.0% | 0.01% | – |
MNKD | New | MANNKIND CORPcall | $94,164 | – | 22,800 | +100.0% | 0.01% | – |
KURA | New | KURA ONCOLOGY INC | $91,656 | – | 10,050 | +100.0% | 0.01% | – |
CMPX | New | COMPASS THERAPEUTICS INC | $88,955 | – | 45,155 | +100.0% | 0.01% | – |
KZR | New | KEZAR LIFE SCIENCES INC | $81,933 | – | 68,851 | +100.0% | 0.01% | – |
New | ERASCA INC | $82,939 | – | 42,101 | +100.0% | 0.01% | – | |
TERN | New | TERNS PHARMACEUTICALS INC | $76,466 | – | 15,202 | +100.0% | 0.01% | – |
IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $68,705 | – | 15,100 | +100.0% | 0.01% | – |
New | TENAYA THERAPEUTICS INC | $71,655 | – | 28,100 | +100.0% | 0.01% | – | |
NSTG | New | NANOSTRING TECHNOLOGIES INC | $62,264 | – | 36,200 | +100.0% | 0.01% | – |
LRMR | New | LARIMAR THERAPEUTICS INC | $47,558 | – | 12,040 | +100.0% | 0.01% | – |
CDTX | New | CIDARA THERAPEUTICS INC | $51,214 | – | 54,356 | +100.0% | 0.01% | – |
New | RENEW ENERGY GLOBAL PLC | $54,300 | – | 10,000 | +100.0% | 0.01% | – | |
NGM | New | NGM BIOPHARMACEUTICALS INC | $36,166 | – | 33,800 | +100.0% | 0.00% | – |
New | TSCAN THERAPEUTICS INC | $42,432 | – | 16,575 | +100.0% | 0.00% | – | |
GRTX | New | GALERA THERAPEUTICS INC | $3,047 | – | 17,400 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DOLE PLC | 4 | Q3 2023 | 50.4% |
GROUPON INC | 4 | Q3 2023 | 36.3% |
NAVIOS MARITIME PARTNERS L P | 4 | Q3 2023 | 6.4% |
ARLO TECHNOLOGIES INC | 4 | Q3 2023 | 8.0% |
KINROSS GOLD CORP | 4 | Q3 2023 | 1.6% |
GLOBAL SHIP LEASE INC NEW | 4 | Q3 2023 | 1.1% |
CENTERRA GOLD INC | 4 | Q3 2023 | 1.1% |
INTERNATIONAL SEAWAYS INC | 3 | Q3 2023 | 7.9% |
TALOS ENERGY INC | 3 | Q3 2023 | 4.8% |
BURFORD CAP LTD | 3 | Q2 2023 | 3.4% |
View Pale Fire Capital SE's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
4 | 2024-01-23 |
4 | 2023-11-20 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-08 |
4 | 2022-12-22 |
3/A | 2022-12-20 |
4 | 2022-09-01 |
View Pale Fire Capital SE's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.